British pharmaceutical giant GlaxoSmithKline said Monday that the European Union has allowed it to market Cervarix -- a drug used to treat cervical cancer.
"The decision (by the European Commission) to approve Cervarix for the European Union represents a great step forward for European women," GSK chief executive JP Garnier said in a statement.
Advertisement"Physicians across Europe will now have access to this important vaccine to help protect women against cervical cancer, the second most common cancer in women," he added.
The EU consists of 27 nations, including Britain, France and Germany.
You May Also Like